Skip navigation
Skip navigation

Real-time prescription drug monitoring program in Australia: We should be ready

Islam, M. Mofizul; McRae, Ian S.


Sir—Referring to the replication of Tasmanian real-time prescription drug monitoring program (PMP) in other Australian states, Nielsen and Bruno, in their recent Editorial [1], raised several key questions that need to be considered. The first question was the range of drugs to be monitored. The proposed PMP will monitor only Schedule-8 controlled drugs which do not cover weaker opioids (e.g. tramadol) and a majority of benzodiazepines.

CollectionsANU Research Publications
Date published: 2015
Type: Journal article
Source: Drug and Alcohol Review
DOI: 10.1111/dar.12242


There are no files associated with this item.

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  20 July 2017/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator